Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history

Authors

Jonathan Marshall
Shigeo Muro (ORCID: https://orcid.org/0000-0001-7452-9191)
Munehiro Seki (ORCID: https://orcid.org/0000-0002-7899-9120)
Elizabeth A. Duncan (ORCID: https://orcid.org/0000-0003-3622-8819)
Hisatoshi Sugiura (ORCID: https://orcid.org/0000-0002-4335-7048)
Mehul S. Patel (ORCID: https://orcid.org/0000-0003-0435-858X)
Ayman Megally
Karin Bowen
Tomotaka Kawayama

Institutions

AstraZeneca (United Kingdom) (GB)
Kurume University (JP)
Tohoku University (JP)
AstraZeneca (Japan) (JP)
AstraZeneca (United States) (US)
Nara Medical University (JP)

Publication Details

Journal: Respiratory Research
Published: 2024-08-05
DOI: https://doi.org/10.1186/s12931-024-02918-8
Citations: 11
Primary Topic: Chronic Obstructive Pulmonary Disease (COPD) Research
Type: article
Field-Weighted Citation Impact: 4.61

Funders

AstraZeneca

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history

Jonathan Marshall, Shigeo Muro, Munehiro Seki, Elizabeth A. Duncan et al.

Aug 5, 2024

11 citations

Respiratory Research

Chronic Obstructive Pulmonary Disease (COPD) Research

4.61

article

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history

Jonathan Marshall, Shigeo Muro, Munehiro Seki, Elizabeth A. Duncan, Hisatoshi Sugiura, Mehul S. Patel, Ayman Megally, Karin Bowen, Tomotaka Kawayama

August 5, 2024article en

11 citations

Abstract

No abstract available for this paper.

Respiratory ResearchVol. 25(1)

AstraZeneca (United Kingdom) (GB), Kurume University (JP), Tohoku University (JP), AstraZeneca (Japan) (JP), AstraZeneca (United States) (US), Nara Medical University (JP)

AstraZeneca

Good health and well-being

Openalex Percentile: Top 5%

Chronic Obstructive Pulmonary Disease (COPD) Research

4.61

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history — Jonathan Marshall, Shigeo Muro, et al. · Respiratory Research (2024) | TGRS Research Map | TGRS